Upon Unilateral Termination by GSK. (a) In the event of a unilateral termination of this Agreement in its entirety or any Project by GSK pursuant to Section 12.3, the following terms shall apply:
Appears in 4 contracts
Samples: Research and Development Collaboration, Option and License Agreement (Anacor Pharmaceuticals Inc), Research and Development Collaboration, Option and License Agreement (Anacor Pharmaceuticals Inc), Research and Development Collaboration, Option and License Agreement (Anacor Pharmaceuticals Inc)
Upon Unilateral Termination by GSK. (a) In the event of a unilateral termination of this Agreement in its entirety or any Project by GSK pursuant to Section 12.3, the following terms shall apply:
Appears in 4 contracts
Samples: Commercialization Agreement, Product Development And (ChemoCentryx, Inc.), Product Development And (ChemoCentryx, Inc.)
Upon Unilateral Termination by GSK. (a) In the event of a unilateral termination of this Agreement in its entirety or any Project Program by GSK pursuant to Section Sections 5.2(b), 7.2 or 12.3, the following terms shall apply:
Appears in 2 contracts
Samples: Collaboration and License Agreement (Orchard Rx LTD), Collaboration and License Agreement (Orchard Rx LTD)
Upon Unilateral Termination by GSK. (a) In the event of a unilateral termination of this Agreement in its entirety or any Project Program by GSK pursuant to Section 12.3, the following terms shall apply:
Appears in 2 contracts
Samples: Research and Development Collaboration (Dynavax Technologies Corp), And License Agreement (Dynavax Technologies Corp)
Upon Unilateral Termination by GSK. (a) In the event of a unilateral termination of this Agreement in its entirety or any Project Program by GSK pursuant to Section Sections 5.3(b), 7.3 or 12.3, the following terms shall apply:
Appears in 2 contracts
Samples: Collaboration and License Agreement (Prosensa Holding B.V.), Collaboration and License Agreement (Prosensa Holding B.V.)
